Related Experiment Videos
[Alpha fetoprotein in non-neoplastic liver diseases]
Minerva Medica
|May 7, 1981
Summary
Alpha-fetoprotein (AFP) levels were studied in various liver conditions. Elevated AFP suggests hepatocellular regeneration in viral or inflammatory liver diseases.
Area of Science:
- Hepatology
- Biochemistry
- Oncology
Context:
- Alpha-fetoprotein (AFP) is a biomarker studied in liver diseases.
- Previous research has examined AFP in hepatitis and hepatocellular carcinoma.
Purpose:
- To investigate seric AFP levels in patients with various liver conditions, including normal subjects, cirrhosis, chronic hepatitis, and hepatomas.
- To correlate AFP levels with specific liver pathologies.
Summary:
- This study examined seric AFP in 65 normal subjects, 62 cirrhoses, 10 active chronic hepatitis, 12 chronic persistent hepatitis, 4 primary biliary cirrhoses, and 9 hepatomas.
- Abnormal AFP levels (> 10 ng/ml) were observed and align with existing literature.
- The findings suggest that hepatocellular regeneration, potentially triggered by viral or inflammatory disorders, may lead to AFP formation via gene regulation mechanisms.
Impact:
- Provides further evidence for AFP as a marker in liver disease.
- Contributes to understanding the pathophysiology of AFP production in liver regeneration and disease.